XML 134 R35.htm IDEA: XBRL DOCUMENT v3.22.2.2
Commitments and Contingencies (Details Narrative) - USD ($)
8 Months Ended 9 Months Ended
Mar. 19, 2022
Nov. 12, 2021
Mar. 26, 2021
Apr. 30, 2019
Dec. 31, 2019
Dec. 31, 2019
Dec. 31, 2019
Feb. 15, 2021
Apr. 11, 2019
Defined Benefit Plan Disclosure [Line Items]                  
Royalty percentage 5.50%                
Development cost $ 1,250,000                
Maiden Biosciences Inc [Member]                  
Defined Benefit Plan Disclosure [Line Items]                  
Executory notes               $ 800,000  
Outstanding principal and interest               $ 4,329,000  
Jeffrey Ronaldi [Member]                  
Defined Benefit Plan Disclosure [Line Items]                  
Wages recover           $ 144,658      
Salaries un-paid                 $ 769
Alleged paid in time off         $ 15,385 15,385 $ 15,385    
Alleged unpaid         3,077 3,077 3,077    
Penalties accured         26,077 26,077 26,077    
Unspecified expense reimbursement             91,000    
Reimbursement of legal fees   $ 121,672.51 $ 160,896.25            
Legal fees   $ 281,443.76 $ 159,771.25            
Jeffrey Ronaldi [Member] | Deferred Bonus [Member]                  
Defined Benefit Plan Disclosure [Line Items]                  
Cash bonus         300,000 300,000 300,000    
Performance bonus         450,000        
Jeffrey Ronaldi [Member] | Deferred Profit Sharing [Member]                  
Defined Benefit Plan Disclosure [Line Items]                  
Cash bonus         $ 100,000 $ 100,000 $ 100,000    
Jeffrey Ronaldi [Member] | 2017 Employment Agreement [Member]                  
Defined Benefit Plan Disclosure [Line Items]                  
Loss contingency, allegations       In April 2019 DSS commenced an action in New York State Supreme Court, Monroe County, Index No. E2019003542, against Jeffrey Ronaldi, our former Chief Executive Officer. This New York action seeks a declaratory judgment that, contrary to informal claims made by him, Mr. Ronaldi’s employment agreement with us expired by its terms and that he is not entitled to any cash bonuses or other unpaid amounts. The lawsuit also seeks an injunction against Mr. Ronaldi from interfering with any of DSS’ IP litigation. Mr. Ronaldi subsequently commenced an action against DSS in the Superior Court of California, County of San Diego, on November 8, 2019, under case number 37-2019-00059664-CU-CO-CTL, in which he alleged that DSS terminated his employment in April 2019 in order to avoid paying him certain employment-related amounts. DSS was successful in dismissing the California case and consolidating it with the action pending in Monroe County, New York. Mr. Ronaldi asserted counterclaims in the Monroe County, New York action similar to those he originally brought in California. Mr. Ronaldi claims that his termination violated an alleged employment agreement or implied-in-fact employment agreement and that he should have remained employed through 2019. Mr. Ronaldi seeks to recover: (i) $144,658 in wages from April 11, 2019 through December 31, 2019; (ii) $769 in alleged unpaid based salary for time worked before April 11, 2019; (iii) $15,385 in alleged paid time off compensation; (iv) $3,077 in alleged unpaid sick time compensation; (v) $26,077 in waiting-time penalties; (vi) $91,000 in unspecified expense reimbursement; (vii) $300,000 in alleged cash bonuses ($100,000 per year) based on DSS’s performance in 2017, 2018 and 2019; and (viii) a $450,000 performance bonus based on the result of certain alleged net proceeds from patent infringement litigation. He further claims an interest in any recovery in DSS Technology Management v. Apple, Inc., Case No. 4:14-cf05330-HSG. The court recently ordered Mr. Ronaldi to produce several categories of documents that he sought to withhold. Discovery is ongoing.